Twice-Yearly Injection 96% Effective in Preventing HIV Infection
A twice-yearly injection of Sunlenca (lenacapavir) reduces the risk of HIV infection by 96%, which is significantly more effective than oral pre-exposure prophylaxis (PrEP) using pills like Truvada, researchers report in the New England Journal of Medicine.
'Huge relief' as new drug found to effectively prevent HIV infection
A vaccination with the drug lenacapavir offers an effective protection against a HIV infection, according to newly published research from the pivotal phase-three study "Purpose 2". The option to vaccinate against HIV only every six months is a genuine breakthrough,
On Worlds AIDS Day, the benefits of PEPFAR, PrEP, and U=U are celebrated. But continuing stigma and decreasing political will ...
GlobalData on MSN1d
PrEP therapies utter new hope in HIV preventive landscape as vaccine failures amassThe HIV vaccine space has seen dwindling research activity as drug manufacturers turn to PrEP therapies for preventive ...
10hon MSN
The number of new HIV infections has fallen over the years—it declined by 39% from 2010 to 2023. But HIV's devastating impact ...
Remarkable progress has been made against the HIV epidemic in the last two decades. However, a loss of momentum in fighting ...
But Woodward said the increase could be slowed down if there was greater uptake in drugs that prevent HIV transmission, ...
The Tampa Bay Times e-Newspaper is a digital replica of the printed paper seven days a week that is available to read on ...
Kenya’s ministry of health has approved the nationwide roll out of a vaginal ring to help women protect themselves from HIV.
In honor of World AIDS Day, The Project of Primary Health Care hosted a gathering Sunday on the steps of the Iowa Capitol to ...
Rwanda will soon introduce a new measure in the fight against HIV/AIDS, based on the use of an injectable pre-exposure prophylaxis (PrEP) drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback